Related Experiment Video
Updated: Aug 5, 2026

Two Methods for Establishing Primary Human Endometrial Stromal Cells from Hysterectomy Specimens
Published on: May 23, 2014
Steroid receptors and endometrial cancer
Abstract:
Like breast carcinomas, endometrial carcinomas are derived from sex steroid target tissue. Progress and research directed into the clinicopathologic relationship of steroid receptors and endometrial carcinomas have been hampered by many factors, including: limited numbers of patients with advanced-stage disease compared to the number with breast carcinoma; contamination of specimens with surrounding benign endometrial components which may contribute to total steroid binding; and amount of tissue required for standard biochemical assays. Nevertheless, several clinicopathological associations have been made for steroid receptor content of endometrial carcinomas. Receptor content appears to correlate with histological differentiation in that well-differentiated lesions have higher mean levels of receptor and more receptor 'positive' lesions than do poorly differentiated lesions. Furthermore, receptor levels and status appear to correlate with prognosis of primary endometrial carcinomas and response to hormonal therapy of advanced endometrial carcinoma. Newer techniques utilizing monoclonal antibodies to directly localize receptor in tissue specimens may lead to a greater understanding of the dynamics of receptor physiology in endometrial carcinomas, and may make possible more accurate predictions of clinical behavior by allowing the direct analysis of the receptor content of the malignant component within a tissue specimen.
Insights
Endometrial carcinoma steroid receptor levels correlate with tumor differentiation and patient prognosis. Newer techniques may improve analysis of receptor content for better clinical predictions.
Area of Science:
- Oncology
- Endocrinology
- Pathology
Background:
- Endometrial carcinomas, like breast cancers, originate from sex steroid-sensitive tissues.
- Research on clinicopathologic relationships of steroid receptors in endometrial cancer is challenged by limited advanced-stage cases, specimen contamination, and assay tissue requirements.
Purpose of the Study:
- To explore the clinicopathological associations of steroid receptor content in endometrial carcinomas.
- To investigate the correlation between steroid receptor levels, histological differentiation, prognosis, and hormonal therapy response.
Main Methods:
- Analysis of clinicopathological data and steroid receptor content in endometrial carcinoma specimens.
- Utilizing newer techniques with monoclonal antibodies for direct receptor localization in tissue.
Main Results:
- Steroid receptor content correlates positively with histological differentiation; well-differentiated lesions show higher receptor levels.
- Receptor levels and status are associated with improved prognosis in primary endometrial carcinomas.
- Receptor status predicts response to hormonal therapy in advanced endometrial carcinoma.
Conclusions:
- Steroid receptor status is a significant factor in endometrial carcinoma differentiation, prognosis, and treatment response.
- Advanced techniques like monoclonal antibody-based localization promise more accurate analysis of receptor content in the malignant component.
- Further research using these methods could enhance understanding of receptor physiology and improve clinical behavior predictions.
Related Concept Videos
Endocrine Signaling
Intracellular Hormone Receptors
Internal Receptors
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.

